 patient with clinically signiﬁcant carotid stenosis is identiﬁed, appropriate treatment must be selected.
Treatment is primarily directed at reducing stroke risk.
The risks associated with an interventional treatment
must be compared with those of optimal medical therapy when treatment choices are made. In general, risk
of stroke, MI, and death are used when comparing transfemoral CAS with CEA. In most clinical trials comparing
transfemoral CAS with CEA, stroke, MI